4.7 Article

Targeted Quantitative Proteomics for the Analysis of 14 UGT1As and-2Bs in Human Liver Using NanoUPLC-MS/MS with Selected Reaction Monitoring

期刊

JOURNAL OF PROTEOME RESEARCH
卷 12, 期 10, 页码 4402-4413

出版社

AMER CHEMICAL SOC
DOI: 10.1021/pr4004213

关键词

UGT1As; UGT2Bs; targeted quantitative proteomics; SIL; nanoUPLC-MS/MS; microsomes; S9s

资金

  1. Pfizer, Inc.
  2. NIH [S10, RR024595]

向作者/读者索取更多资源

Targeted quantitative proteomics using heavy isotope dilution techniques is increasingly being utilized to quantify proteins, including UGT enzymes, in biological matrices. Here we present a multiplexed method using nanoLC-MS/MS and multiple reaction monitoring (MRM) to quantify 14 UGT1As and UGT2Bs in liver matrices. Where feasible, we employ two or more proteotypic peptides per protein, with only four proteins quantified with only one proteotypic peptide. We apply the method to analysis of a library of 60 human liver microsome (HLM) and matching S9 samples. Ten of the UGT isoforms could be detected in liver, and the expression of each was consistent with mRNA expression reported in the literature. UGT2B17 was unusual in that similar to 30% of liver microsomes had no or little (<0.5 pmol/mg protein) content, consistent with a known common polymorphism. Liver S9 UGT concentrations were approximately 10-15% those of microsomes. The method was robust, precise, and reproducible and provides novel UGT expression data in human liver that will benefit rational approaches to evaluate metabolism in drug development.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据